SCHEMBL5608290

SCHEMBL5608290

CSNS(=O)(=O)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.56
KIF11 P52732 1/20 0.50
HDAC1 Q13547 3/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC3 O15379 2/20 0.48
HDAC4 P56524 2/20 0.48
HDAC7 Q8WUI4 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC9 Q9UKV0 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47
PTGS2 P35354 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MMP1 P03956 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2371771 0.81 SMN1; SMN2 (0.63) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL6126254 0.80 FFAR4 (0.49) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL18881395 0.79 CA1 (0.61) FFAR4SMN1; SMN2MMP1MMP2MMP9
SCHEMBL514383 0.78 PTGS2 (0.65) FFAR4KIF11BCHEACHEPTGS2
SCHEMBL16060627 0.78 FFAR4 (0.57) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL419333 0.77 FFAR4 (0.56) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL2371770 0.77 FFAR4 (0.56) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL8012671 0.77 FFAR4 (0.56) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL13412196 0.77 FFAR4 (0.56) FFAR4KIF11HDAC1HDAC8HDAC3
SCHEMBL14459390 0.76 ALDH1A1 (0.70) FFAR4KIF11HDAC1HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-7119120-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2006-10-10 US disclosed
EP-1465638-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2004-10-13 EP disclosed
US-20040019113-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003057225-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019113-A1 Phosphate transport inhibitors SLC34A1, SLC34A2, SLC20A1 FFAR4 894/4885KIF11 4782/4885HDAC1 2271/4885
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 FFAR4 2368/4885KIF11 4700/4885HDAC1 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.